News Chart LifeTech Scientific Corporation

Equities

1302

KYG548721177

Market Closed - Hong Kong S.E. Other stock markets 04:08:17 2024-05-17 am EDT			5-day change	1st Jan Change
1.93 ^HKD	+2.12%		+9.66%	-17.87%

May. 16	LifeTech Scientific Completes Follow-up of Phase 2 Clinical Study of IBS Coronary Scaffold	MT
May. 15	LifeTech Scientific Corporation Announces One-Year Follow-Up Results of Phase II Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System	CI

2d88798b2ba236b.Trbix9Id6LcYaeS6DFBLVbwdE1xwKGQ5E5zExPrdxLk.O8atsY1Qv8RrEabYdmcaN_RNJGwFH0lNQq6tkKmZt9grgpH3gG2c7UJepQ~54731ce0653b145e364ceeb52c1fe094